Patents by Inventor Ernest L. Bonner, Jr.

Ernest L. Bonner, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7884090
    Abstract: The present invention provides compositions, combination of medicaments, and methods for the treatment of certain conditions such as arthritis, and in particular, reactive arthritis, osteoarthritis, and bursitis, among others.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: February 8, 2011
    Inventors: Ernest L. Bonner, Jr., Robert Hines
  • Patent number: 7691831
    Abstract: A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member from each of the following groups of medications: (1) synthetic purine nucleoside analog antiviral drugs, (2) antibiotic drugs, and (3) imidazole drugs. Alternate embodiments of the invention include dual combinations of (A) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the antibiotic group of drugs, (B) a member of the antibiotic group of drugs and a member of the imidazole family of drugs, and (C) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the imidazole group of drugs.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: April 6, 2010
    Inventors: Ernest L. Bonner, Jr., Robert Hines
  • Patent number: 7053073
    Abstract: A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole.
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: May 30, 2006
    Assignee: Ficaar, Inc.
    Inventors: Ernest L. Bonner, Jr., Robert Hines
  • Patent number: 6765000
    Abstract: A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of acyclovir, minocycline hydrochloride, and metronidazole. An alternate treatment comprises the combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: July 20, 2004
    Inventors: Ernest L. Bonner, Jr., Robert Hines
  • Patent number: 6465473
    Abstract: An improved method for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of L-lysine, minocycline hydrochloride, metronidazole, and valacyclovir hydrochloride. A first alternate method comprises administration of L-lysine, minocycline hydrochloride, and metronidazole. A second alternate method comprises administration of L-lysine, minocycline hydrochloride, metronidazole, and isonicotinic acid hydrazide.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: October 15, 2002
    Inventors: Ernest L. Bonner, Jr., Robert Hines
  • Publication number: 20010003120
    Abstract: An improved method of treating male erectile dysfunction by enteral administration of a combination of sildenafil citrate and papavarine hydrochloride. An alternate mode of treatment indicated for individuals with known vascular disease includes the contemporaneous administration of pentoxifylline. Further embodiments include administration of zinc monomethionine aspartate.
    Type: Application
    Filed: May 14, 1999
    Publication date: June 7, 2001
    Inventors: ROBERT HINES, M. D., ERNEST L. BONNER, JR. M. D.
  • Patent number: 6197776
    Abstract: An improved method for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of acyclovir, L-lysine, minocycline hydrochloride, and metronidazole. An alternate method comprises administration of isonicotinic acid hydrazide.
    Type: Grant
    Filed: July 10, 2000
    Date of Patent: March 6, 2001
    Inventors: Ernest L. Bonner, Jr., Robert Hines
  • Patent number: 6087382
    Abstract: An improved method for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of L-lysine, minocycline hydrochloride, isonicotinic acid hydrazide, and metronidazole.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: July 11, 2000
    Inventors: Ernest L. Bonner, Jr., Robert Hines